Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medicenna Therapeutics Corp (MDNA)
NASDAQ:MDNA
Medicenna Therapeutics Corp (MDNA) Stock Forecast & Price Target
154 Followers
See the Price Targets and Ratings of:
MDNA Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MDNA Stock 12 Month Forecast
Average Price Target
―| Highest Price Target$5.98 | Average Price Target$3.26 | Lowest Price Target$1.59 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Research Capital
Reiterated
10/27/23
H.C. Wainwright
Reiterated
08/10/23
Guggenheim
$1.46
Buy
―
Initiated
11/29/22
Guggenheim Initiates Coverage On Medicenna Therapeutics with Buy Rating, Announces Price Target of C$2
Best Analysts Covering Medicenna Therapeutics Corp
Which Analyst Should I Follow If I Want to Buy MDNA and Sell After:
1 Month
3 Months
1 Year
Success Rate
0/15 ratings generated profit
Average Return
-60.72%
reiterated a buy rating 9 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -60.72% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MDNA Analyst Recommendation Trends
Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
MDNA Financial Forecast
MDNA Stock Forecast FAQ
What is MDNA’s average 12-month price target, according to analysts?
Based on analyst ratings, Medicenna Therapeutics Corp’s 12-month average price target is $3.26.
What is MDNA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MDNA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MDNA a Buy, Sell or Hold?
Medicenna Therapeutics Corp has a conensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Medicenna Therapeutics Corp’s price target?
The average price target for Medicenna Therapeutics Corp is $3.26. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $5.98 ,the lowest forecast is $1.59. The average price target represents N/A Increase from the current price of N/A.
The highest analyst price target is $5.98 ,the lowest forecast is $1.59. The average price target represents N/A Increase from the current price of N/A.
What do analysts say about Medicenna Therapeutics Corp?
Medicenna Therapeutics Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of MDNA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.